Close Menu

    Subscribe to Updates

    Get the latest creative news from Healthradar about News,Health and Gadgets.

    Bitte aktiviere JavaScript in deinem Browser, um dieses Formular fertigzustellen.
    Wird geladen
    What's Hot

    Casio’s F-B100W retro smartwatch launches in the US — $65 tracker lands with Bluetooth and step-tracking after selling out in Japan

    30. September 2026

    Abbott launches Freenome’s colorectal cancer screening test

    30. September 2026

    Sofinnova raises 82M euros to fund medtech startups

    29. September 2026
    Facebook X (Twitter) Instagram
    Facebook X (Twitter) Instagram Pinterest Vimeo
    healthradar.nethealthradar.net
    • Home
    • Ai
    • Gadgets
    • Health
    • News
    • Contact Us
    Contact
    healthradar.nethealthradar.net
    Home»Health»Eli Lilly’s obesity pill remains a viable rival to Novo’s oral Wegovy despite data that underwhelmed investors
    Health

    Eli Lilly’s obesity pill remains a viable rival to Novo’s oral Wegovy despite data that underwhelmed investors

    HealthradarBy Healthradar25. August 2025Keine Kommentare1 Min Read
    Share Facebook Twitter Pinterest LinkedIn Tumblr Reddit Telegram Email
    Eli Lilly’s obesity pill remains a viable rival to Novo’s oral Wegovy despite data that underwhelmed investors
    Share
    Facebook Twitter LinkedIn Pinterest Email


    Eli Lilly’s obesity pill remains a viable rival to Novo’s oral Wegovy despite data that underwhelmed investors submitted by /u/cnbc_official
    [comments]



    Source link

    data Eli investors Lillys Novos Obesity Oral Pill Remains rival underwhelmed viable Wegovy
    Share. Facebook Twitter Pinterest LinkedIn Tumblr Email
    Previous ArticleRansomware attack on DaVita exposes data from 2.7M
    Next Article Twin Health Secures $53M Financing Following Cleveland Clinic Trial Results
    ekass777x
    Healthradar
    • Website

    Related Posts

    Ai

    Everyone is talking about an Apple Whoop-style screenless fitness band: here are 3 features it needs to rival Fitbit and Garmin’s trending trackers

    26. September 2026
    Ai

    Amazfit’s new solar-powered AMOLED smartwatch aims to rival Garmin’s legendary battery life — you can even wear it inside out for maximum light absorption

    22. September 2026
    News

    Why LLMs Cannot Replace Deterministic Data Infrastructure

    18. September 2026
    Add A Comment
    Leave A Reply Cancel Reply

    Top Posts

    Marvel’s Dyasonic: A Superhero Powered by Sound—and Diabetes Tech

    13. Juni 2025828 Views

    Tombot Secures $6.1M to Bring Lifelike Robotic Puppy to Seniors with Dementia –

    19. Juni 2025806 Views

    Luna ring review | TechRadar

    26. Dezember 2025199 Views

    Hims & Hers Acquires Australian Digital Health Eucalyptus for Up to $1.15B

    20. Februar 2026167 Views
    Stay In Touch
    • Facebook
    • YouTube
    • TikTok
    • WhatsApp
    • Twitter
    • Instagram
    Latest Reviews

    Subscribe to Updates

    Bitte aktiviere JavaScript in deinem Browser, um dieses Formular fertigzustellen.
    Wird geladen
    About Us

    Welcome to HealthRadar.net — your trusted destination for discovering the latest innovations in digital health. We are dedicated to connecting individuals, healthcare professionals, and organizations with cutting-edge tools, applications

    Most Popular

    Marvel’s Dyasonic: A Superhero Powered by Sound—and Diabetes Tech

    13. Juni 2025828 Views

    Tombot Secures $6.1M to Bring Lifelike Robotic Puppy to Seniors with Dementia –

    19. Juni 2025806 Views
    USEFULL LINK
    • About Us
    • Contact Us
    • Disclaimer
    • Privacy Policy
    QUICK LINKS
    • Ai
    • Gadgets
    • Health
    • News
    • About Us
    • Contact Us
    • Disclaimer
    • Privacy Policy
    Copyright© 2025 Healthradar All Rights Reserved.

    Type above and press Enter to search. Press Esc to cancel.